Overview

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2008-04-17
Target enrollment:
Participant gender:
Summary
A Phase I/II study to investigate the safety, pharmacokinetics and pharmacodynamics of GSK716155 in Japanese subjects with type 2 diabetes mellitus
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline